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SI Materials and Methods
miR-146a KO Mice. Brieﬂy, a targeting construct where 295 base
pairs of genomic sequence containing mouse premiR-146a were
replaced with a ﬂoxed neomycin expression cassette was elec-
troporated into Bruce4 ES cell line to generate miR-146a−/−
mouse on the pure C57BL/6 background. Absence of miR-146a
expression was conﬁrmed in various hematopoietic organs by
Northern blotting. Subsequent genotyping was done by duplex
PCR with primers mir146a-WT-F (5′ - CTT GGA CCA GCA
GTC CTC TTG ATG CAC CTT - 3′), mir146a-KO-F (5′ - ATC
GCG GCC GCT TTA AGT GTA GAG AGG GGG TCA AGT
A - 3′), and mir146a-R (5′ - ATT GCT CAG CGG TGC TGT
CCA TCT GCA CGA - 3′) and the following PCR conditions:
94 °C for 3 min; 94 °C for 30 s, 55 °C for 30 s, 72 °C for 1 min, for
35 cycles; 72 °C for 10 min. The wild-type allele is about 900 bp
and KO allele is about 700 bp.
Histology, Immunohistochemistry, and Complete Blood Count. For
histological and immunohistochemical analysis, necropsied organs
were ﬁxed in 10% neutral-buffered formalin. All histology, im-
munohistochemistry, and complete blood count analysis were
performed by the University of California, Los Angeles Pathology
Research Services.
Quantitative RT-PCR. Total RNA was extracted with TRIzol re-
agent (Invitrogen) from total nucleated splenocytes, bonemarrow
cells, and CD11b+-enriched splenocytes after red blood cell lysis
(Biolegend). CD11b+ enriched splenocytes were puriﬁed by
CD11b antibody-conjugated MACS beads (Miltenyi Biotec) ac-
cording to the manufacturer’s instructions. cDNA was synthe-
sized using iScript cDNA synthesis kit (Bio-Rad) followed by
SYBR Green-based quantitative PCR (Applied Biosystems), as
previously described (1). Rpl32 level was used as the normali-
zation.
Western Blot Analysis.Nuclear protein lysates were extracted using
nuclear extraction kit (Sigma) according to the manufacturer’s
instructions. Antibodies against p65 (sc-8008 and sc-372), lam-
inA/C (sc-20681), and HRP-conjugated secondary antibody (sc-
2031 and sc-2004, all from Santa Cruz Biotechnology) were used
for detection.
Flow Cytometry. Cells were harvested, homogenized, and red
blood cells lysed with red blood cell lysis buffer (Biolegend).
Fluorophore-conjugated antibodies against CD3ε, CD11b,
CD19, Ter119, Gr1 (all from Biolegend) and CSF1R (Ebio-
science) were used for staining. Cells were analyzed on
a FACSCalibur (BD Bioscience) machine and data analysis was
performed with FloJo software (Tree Star).
Statistical Analysis. All statistical analyses were performed using
Prism 5 software (GraphPad). The log-rank Mantel-Cox test was
used to determine statistical signiﬁcance in Kaplan-Meier survival
curve. The χ2 test was used to compare tumor incidence between
wild-type and miR-146a−/− mice and between the expected and
observed distribution of offspring from p50+/− miR-146a+/− in-
tercross. Relationship between spleen weight and percent CD11b
was analyzed with correlation test. All other statistical analyses
were performedwith theF-test ﬁrst to determinewhether variances
are different and then with the correct Student t test. P values less
than 0.05 in t tests were considered statistically signiﬁcant.
1. O’Connell RM, et al. (2008) Sustained expression of microRNA-155 in hematopoietic
stem cells causes a myeloproliferative disorder. J Exp Med 205:585–594.
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Fig. S1. miR-146a–deﬁcient mice develop myeloproliferation in spleens. Mice were 18- to 22-mo-old miR-146a−/− mice (KO), miR-146a+/− mice (HET), and sex-
and age-matched C57BL/6 control mice (WT). Data are shown as mean ± SEM. Each individual dot represents one individual mouse. At least three independent
experiments were performed. (A) Kaplan-Meier survival curve of aging miR-146a KO and wild-type mice starting at 1 y of age (n = 39 for WT and n = 43 for KO).
(B) Photographs of spleens isolated from KO and wild-type mice. (C) Weight of spleens isolated from KO, HET, and wild-type mice (n = 26 for WT, n = 5 for HET,
and n = 33 for KO). (D) Flow cytometric analysis of nucleated splenocytes from one representative KO mouse and one representative wild-type mouse for T cells
(deﬁned as CD3ε+), B cells (deﬁned as CD19+), myeloid cells (deﬁned as CD11b+), and erythroid cells (deﬁned as Ter119+). (E) Percentage of T cells, B cells,
myeloid cells, and erythroid cells, as deﬁned above, in nucleated splenocytes in KO and wild-type mice by ﬂow cytometry (n = 15 for WT and n = 21 for KO from
at least three independent experiments). (F) Correlation between spleen weight and percentage CD11b+ cells in spleen from 18- to 22-mo-old miR-146a–
deﬁcient mice (n = 19).
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Fig. S2. Additional examples of myeloid and lymphoid malignancies in miR-146a–deﬁcient mice. (A) Photograph, FACS plot, and histological analysis of
a representative myeloid tumor inﬁltrating a KO liver. Panels 3 and 4 show an H&E-stained liver section. Liv, residual liver, MS, myeloid sarcoma inﬁltration.
[Scale bars, (panel 3) 200 μm; (panel 4) 40 μm.] Arrows, apoptotic hepatocytes at the edge of the inﬁltrate. (B) Photograph, FACS plot, and histological analysis
of a representative myeloid tumor inﬁltrating a KO kidney. Panels 3 and 4 show an H&E-stained kidney section. Kid, residual uninvolved kidney; MS, myeloid
sarcoma inﬁltration. [Scale bars, (panel 3) 200 μm; (panel 4) 40 μm.] Arrow, markedly atypical mitotic ﬁgure. (C) Photograph, FACS plot, and histological
analysis of a representative B-cell lymphoma from a KO cervical lymph node. Panels 3 and 5 show an H&E-stained spleen section. Panel 4: Positive immu-
nohistochemical staining for B220. [Scale bar, 100 μm (panels 3 and 4); 40 μm (panel 5).] (D) Photograph, FACS plot, and histological analysis of a representative
mixed T- and B-cell lymphoma from a KO gastrointestinal tract. Panels 3–5 show an H&E-stained tumor section. [Scale bars, (Left to Right) 200 μm, 100 μm, and
40 μm.] Arrow on panel 4, apoptotic body (“starry sky appearance”); arrowhead on panel 5, large immunoblastic cell (there are many more in this ﬁeld); arrow
on panel 5, atypical mitotic ﬁgure.
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Fig. S3. Cell count and ﬂow cytometric analysis of peripheral blood, spleen, and bone marrow. (A) Complete blood count of peripheral blood from 18- to
22-mo-old miR-146a−/− mice (KO, n = 8) and sex- and age-matched wild-type control mice (WT, n = 8). Data are shown as mean ± SEM. Each individual dot
represents one individual mouse. n.s., not signiﬁcant. (B) Percentage of CD11b/Gr1 double-positive cells and CD11b/CSF1R double-positive cells in spleen, bone
marrow (BM), and peripheral blood (PB) of 18- to 22-mo-old miR-146a−/− mice (KO) and sex- and age-matched wild-type control mice (WT). Data are shown as
mean ± SEM. Each individual dot represents one individual mouse. Total number of mice ranges from 6 to 11 from three independent experiments. n.s., not
signiﬁcant. (C) Photograph of representative tibias and ﬁbulas isolated from wild-type or KO mice.
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Fig. S4. Western blot analysis of the nuclear protein extracts from spleens of 18- to 22-mo-old miR-146a−/− mice (KO) and sex- and age-matched wild type
control. KO (T), KO spleen with myeloid sarcoma; KO, KO spleen without myeloid sarcoma.
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Fig. S5. (A) Number of offspring (n = 173) produced from p50+/−miR-146a+/− double heterozygote intercross. (B) Photograph of tibias from wild-type, miRKO,
miRKO p50HET, and DKO mice.
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